Fresenius medical care ag
FMS 投資分析
看多重點：
- 價值≥4
- 股利≥2
分析結論
價值面評分優異，股利評分名列前茅，值得長期累積部位。若想獲得較好的進場時機，可參考技術面趨勢與波段評分
FMS 近期報酬表現
-0.54%
Fresenius medical care ag
6.23%
同產業平均
1.02%
S&P500
與 FMS 同產業的標的表現
| 股票代碼 | 公司名稱 | 價值 | 趨勢 | 波段 | 籌碼 | 股利 | 加入追蹤 |
|---|---|---|---|---|---|---|---|
DVA | Davita inc | 4 分 | 4 分 | 4 分 | 2 分 | 1 分 | |
HCSG | Healthcare services group inc | 3 分 | 2 分 | 1 分 | 3 分 | 1 分 | |
SGRY | Surgery partners inc | 3 分 | 3 分 | 2 分 | 4 分 | 1 分 | |
AMWL | American well corp | 3 分 | 1 分 | 1 分 | 3 分 | 1 分 | |
CYH | Community health systems, inc. | 3 分 | 3 分 | 3 分 | 2 分 | 1 分 |
- DVA Davita inc價值 4 分趨勢 4 分波段 4 分籌碼 2 分股利 1 分查看更多
FMS 公司資訊
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.